Kainos Medicine, Inc. (KOSDAQ:284620)
South Korea · Delayed Price · Currency is KRW 1,087.00
-105.00 (-8.81%)
At close: Aug 14, 2025
Kainos Medicine Market Cap
Kainos Medicine has a market cap or net worth of 35.56 billion as of October 16, 2026. It is the 34,892nd most valuable company in the world and the 2,034th biggest in South Korea. Its market cap has decreased by 68.69% in one year.
Market Cap
35.56B
Enterprise Value
37.38B
Revenue
1.40B
Global Rank
Country Rank
#2,034 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since June 9, 2020, Kainos Medicine's market cap has decreased from 434.22B to 35.56B, a decrease of -91.81%. That is a compound annual growth rate of -38.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 35.56B | -60.20% |
| Dec 30, 2024 | 89.33B | -25.94% |
| Dec 28, 2023 | 120.62B | 5.37% |
| Dec 29, 2022 | 114.48B | -59.11% |
| Dec 30, 2021 | 279.94B | -40.72% |
| Dec 30, 2020 | 472.24B | 8.76% |
| Jun 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NovMetaPharma | 53.10B |
| TegoScience | 53.00B |
| KoBioLabs | 52.04B |
| J2KBIO | 48.24B |
| QuadMedicine | 46.33B |
| Parataxis Korea | 44.13B |
| Epibiotech | 43.62B |
| HLB Pep | 40.51B |